China Pharma Holdings, Inc. (NYSE:CPHI – Get Free Report) traded down 0.2% during trading on Wednesday . The stock traded as low as $1.58 and last traded at $1.60. 18,880 shares were traded during trading, a decline of 71% from the average session volume of 64,907 shares. The stock had previously closed at $1.60.
Analyst Ratings Changes
Separately, Wall Street Zen raised shares of China Pharma from a “sell” rating to a “hold” rating in a research report on Wednesday, May 21st.
Read Our Latest Research Report on CPHI
China Pharma Stock Down 0.2%
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- Election Stocks: How Elections Affect the Stock Market
- Is Consumer Discretionary a Dead End? These 3 Stocks Say No
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile
- 3 Warren Buffett Stocks to Buy Now
- Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.